Transcriptomic Study of ER 4017 Topical Application in Elderly Subject
NCT00818545
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Aging
Interventions
DRUG:
ER4017 (hydroxypropyltetrahydropyrantriol)
DRUG:
placebo
Sponsor
L'Oreal